Tetmodis 25 mg Tabletten

Recall | Medicines | 26/02/2020

The marketing authorisation holder informed its customers on February 26, 2020 that the mentioned batch will be recalled due to a possible reduced content of the active pharmaceutical ingredient.

Name of the medicinal product Tetmodis 25 mg Tabletten
Marketing authorisation number(s) 1-29793
CIP code 3515555
Marketing authorisation holder AOP Orphan Pharmaceuticals AG
Batch number(s) T1704AT
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-3143

Further inquiry note